| Q93000816 | A Mechanism for Statin-Induced Susceptibility to Myopathy |
| Q41147415 | A TGF-β pathway associated with cancer cachexia |
| Q39310989 | A change of heart: oxidative stress in governing muscle function? |
| Q37761772 | A rapid approach for the detection, quantification, and discovery of novel sulfenic acid or S-nitrosothiol modified proteins using a biotin-switch method. |
| Q89842749 | AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy |
| Q40390266 | Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable |
| Q26852587 | Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance |
| Q36422465 | Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. |
| Q37805925 | Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle. |
| Q38838750 | Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? |
| Q42483409 | Age-related regulation of excitation-contraction coupling in rat heart |
| Q37601041 | Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart |
| Q34335939 | Altered cross-bridge properties in skeletal muscle dystrophies |
| Q35116100 | Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment |
| Q36837270 | Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy |
| Q33589145 | Androgen receptors in muscle fibers induce rapid loss of force but not mass: implications for spinal bulbar muscular atrophy. |
| Q90005528 | Antioxidant supplements and endurance exercise: Current evidence and mechanistic insights |
| Q35977425 | Antioxidants protect calsequestrin-1 knockout mice from halothane- and heat-induced sudden death |
| Q39424672 | Are Antioxidants a Potential Therapy for FSHD? A Review of the Literature |
| Q91957452 | Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases |
| Q35997011 | Assessment of muscle mass and strength in mice |
| Q47709918 | Association of FK506 binding proteins with RyR channels - effect of CLIC2 binding on sub-conductance opening and FKBP binding. |
| Q91627122 | Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy |
| Q35915888 | Blockage of the Ryanodine Receptor via Azumolene Does Not Prevent Mechanical Ventilation-Induced Diaphragm Atrophy |
| Q39302913 | Ca2+ Release Channels Join the 'Resolution Revolution'. |
| Q39493909 | Ca2+ cycling and new therapeutic approaches for heart failure |
| Q46308630 | Ca2+-dependent proteolysis of junctophilin-1 and junctophilin-2 in skeletal and cardiac muscle |
| Q27001582 | Ca2+-dependent regulations and signaling in skeletal muscle: from electro-mechanical coupling to adaptation |
| Q90194088 | Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations |
| Q36497155 | Calcium cycling proteins and heart failure: mechanisms and therapeutics |
| Q37072276 | Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia. |
| Q64105856 | Cancer- and Chemotherapy-Induced Musculoskeletal Degradation |
| Q38493236 | Cancer-associated muscle weakness: What's bone got to do with it? |
| Q92825511 | Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy |
| Q38103213 | Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers. |
| Q36736081 | Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies |
| Q35048166 | Catecholamine-independent heart rate increases require Ca2+/calmodulin-dependent protein kinase II. |
| Q91986708 | Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity |
| Q42720847 | Comparison of Reductive Ligation-Based Detection Strategies for Nitroxyl (HNO) and S-Nitrosothiols |
| Q38751812 | Coupling of excitation to Ca2+ release is modulated by dysferlin. |
| Q26770423 | Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease |
| Q39225878 | Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy |
| Q87368518 | Dihydropyridine receptors actively control gating of ryanodine receptors in resting mouse skeletal muscle fibres |
| Q38480698 | Drug Discovery of Therapies for Duchenne Muscular Dystrophy |
| Q24336808 | Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases |
| Q89782554 | Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies |
| Q98185959 | Dysregulation of RyR Calcium Channel Causes the Onset of Mitochondrial Retrograde Signaling |
| Q38257886 | Dysregulation of calcium homeostasis in muscular dystrophies. |
| Q53636857 | Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage. |
| Q37111473 | Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle |
| Q44882443 | Editorial for "Methods for analysis of nitric oxide signalling by S-nitrosylation". |
| Q28535427 | Effect of Calstabin1 depletion on calcium transients and energy utilization in muscle fibers and treatment opportunities with RyR1 stabilizers |
| Q35051963 | Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice. |
| Q35690856 | Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies |
| Q30512833 | Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters. |
| Q36048495 | Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease |
| Q34800076 | Ethanol enhances carbachol-induced protease activation and accelerates Ca2+ waves in isolated rat pancreatic acini |
| Q41902894 | Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy |
| Q36258000 | Excess TGF-β mediates muscle weakness associated with bone metastases in mice |
| Q42046918 | Excitation-Contraction Coupling Alterations in Myopathies |
| Q90603132 | Exploiting Peptidomimetics to Synthesize Compounds That Activate Ryanodine Receptor Calcium Release Channels |
| Q43146405 | Extinguishing intracellular calcium leak: a promising antiarrhythmic approach |
| Q42005319 | FKBP12.6 activates RyR1: investigating the amino acid residues critical for channel modulation |
| Q41683737 | Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle. |
| Q46060420 | Fixing the leak |
| Q36309327 | Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts. |
| Q38412593 | GSNOR Deficiency Enhances In Situ Skeletal Muscle Strength, Fatigue Resistance, and RyR1 S-Nitrosylation Without Impacting Mitochondrial Content and Activity |
| Q28085320 | Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy |
| Q34059173 | Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy |
| Q34409213 | Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging |
| Q34792390 | High throughput screening in duchenne muscular dystrophy: from drug discovery to functional genomics |
| Q28591442 | Hsp72 preserves muscle function and slows progression of severe muscular dystrophy |
| Q38554891 | Human sports drug testing by mass spectrometry |
| Q37657529 | Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation. |
| Q39120000 | Hyperthermic seizures and aberrant cellular homeostasis in Drosophila dystrophic muscles. |
| Q34121401 | Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure |
| Q36033118 | Increased resting intracellular calcium modulates NF-κB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes |
| Q44826878 | Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy |
| Q34542698 | Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2. |
| Q36707428 | Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy. |
| Q34485229 | Intense resistance exercise induces early and transient increases in ryanodine receptor 1 phosphorylation in human skeletal muscle |
| Q37011991 | Interactions between sarco-endoplasmic reticulum and mitochondria in cardiac and skeletal muscle - pivotal roles in Ca²⁺ and reactive oxygen species signaling |
| Q48112565 | Intracellular calcium release channels: an update. |
| Q39791357 | Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes |
| Q37452338 | Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice |
| Q24295360 | Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy |
| Q37181836 | Leaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation |
| Q40120301 | Leaky ryanodine receptors delay the activation of store overload-induced Ca2+ release, a mechanism underlying malignant hyperthermia-like events in dystrophic muscle |
| Q42149020 | Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy. |
| Q36202652 | Lipogenesis mitigates dysregulated sarcoplasmic reticulum calcium uptake in muscular dystrophy |
| Q26799652 | Malignant hyperthermia: a review |
| Q33911293 | Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer |
| Q34985557 | Mass spectrometric analysis and mutagenesis predict involvement of multiple cysteines in redox regulation of the skeletal muscle ryanodine receptor ion channel complex |
| Q89480969 | Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators |
| Q28383415 | Mechanism-based triarylphosphine-ester probes for capture of endogenous RSNOs |
| Q39100152 | Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings. |
| Q33950716 | Mechanisms of muscle weakness in muscular dystrophy |
| Q38102887 | Methods for detection and characterization of protein S-nitrosylation |
| Q33647871 | Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle |
| Q28393648 | Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity |
| Q34627089 | Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle |
| Q35213316 | Mitochondrial calcium uptake regulates rapid calcium transients in skeletal muscle during excitation-contraction (E-C) coupling |
| Q35447198 | Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure. |
| Q52605494 | Modulation of contractile apparatus Ca2+ sensitivity and disruption of excitation-contraction coupling by S-nitrosoglutathione in rat muscle fibres. |
| Q89985565 | Molecular regulation of skeletal muscle mass and the contribution of nitric oxide: A review |
| Q34720150 | Multiple actions of phi-LITX-Lw1a on ryanodine receptors reveal a functional link between scorpion DDH and ICK toxins |
| Q41688477 | Muscle Weakness in Rheumatoid Arthritis: The Role of Ca2+ and Free Radical Signaling. |
| Q86291937 | Muscular dystrophies |
| Q51781252 | NO may prompt calcium leakage in dystrophic muscle. |
| Q57292416 | Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy |
| Q36394350 | Nanospan, an alternatively spliced isoform of sarcospan, localizes to the sarcoplasmic reticulum in skeletal muscle and is absent in limb girdle muscular dystrophy 2F. |
| Q35986842 | Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy |
| Q43289460 | Negative modulation of inositol 1,4,5-trisphosphate type 1 receptor expression prevents dystrophin-deficient muscle cells death |
| Q47983739 | Neuromuscular diseases in children: a practical approach |
| Q28390869 | Neuronal nitric oxide synthase is dislocated in type I fibers of myalgic muscle but can recover with physical exercise training |
| Q46585617 | Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy |
| Q35069506 | Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice |
| Q38153038 | Nitric Oxide-Induced Calcium Release: Activation of Type 1 Ryanodine Receptor, a Calcium Release Channel, through Non-Enzymatic Post-Translational Modification by Nitric Oxide |
| Q37309661 | Nitric Oxide-induced Activation of the Type 1 Ryanodine Receptor Is Critical for Epileptic Seizure-induced Neuronal Cell Death. |
| Q38196172 | Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease |
| Q40514382 | Nitric oxide-induced calcium release via ryanodine receptors regulates neuronal function |
| Q41566729 | Nitric oxide-induced calcium release: activation of type 1 ryanodine receptor by endogenous nitric oxide |
| Q36150149 | Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness |
| Q35027817 | Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice |
| Q41834889 | Nitrosative stress in human skeletal muscle attenuated by exercise countermeasure after chronic disuse. |
| Q28072269 | Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture |
| Q47404613 | Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model |
| Q46262861 | Oxidative stress, NF-κB and the ubiquitin proteasomal pathway in the pathology of calpainopathy |
| Q34213979 | Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4 |
| Q84043011 | Passive stretch reduces calpain activity through nitric oxide pathway in unloaded soleus muscles |
| Q36169155 | Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia |
| Q39410461 | Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy |
| Q48219682 | Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor |
| Q35974809 | Porcine models of muscular dystrophy |
| Q35020178 | Protein S-nitrosylation in health and disease: a current perspective |
| Q43279398 | Protein denitrosylation: enzymatic mechanisms and cellular functions. |
| Q34171097 | Proteomic identification of S-nitrosylated Golgi proteins: new insights into endothelial cell regulation by eNOS-derived NO. |
| Q37676955 | Proteomic profiling of x-linked muscular dystrophy |
| Q37166776 | Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry |
| Q30576097 | Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function |
| Q42452644 | Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers. |
| Q64447696 | Recovery of respiratory function in mdx mice co-treated with neutralizing interleukin-6 receptor antibodies and urocortin-2 |
| Q26774782 | Redox Characterization of Functioning Skeletal Muscle |
| Q39059046 | Redox Control of Skeletal Muscle Regeneration. |
| Q42380533 | Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice |
| Q35033112 | Regulation of Ryanodine Receptor Ion Channels Through Posttranslational Modifications |
| Q42663223 | Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation |
| Q55000730 | Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse. |
| Q47959400 | Respiratory muscle contractile inactivity induced by mechanical ventilation in piglets leads to leaky ryanodine receptors and diaphragm weakness |
| Q28078420 | Review of RyR1 pathway and associated pathomechanisms |
| Q89459214 | Role of defective Ca2+ signaling in skeletal muscle weakness: Pharmacological implications |
| Q28511926 | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction |
| Q89532069 | RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca2+ assays |
| Q58600210 | Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches |
| Q52339083 | Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure. |
| Q49721336 | Ryanodine Receptor Structure and Function in Health and Disease |
| Q47665947 | Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy |
| Q36279483 | Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease |
| Q33912937 | Ryanodine receptor channelopathies |
| Q36394470 | Ryanodine receptor fragmentation and sarcoplasmic reticulum Ca2+ leak after one session of high-intensity interval exercise. |
| Q28508488 | Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion |
| Q37687548 | Ryanodine receptor mutations in arrhythmia: The continuing mystery of channel dysfunction. |
| Q36949333 | Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. |
| Q38054907 | Ryanodine receptor patents |
| Q37705608 | Ryanodine receptor studies using genetically engineered mice |
| Q38217975 | Ryanodine receptors: physiological function and deregulation in Alzheimer disease. |
| Q34024377 | Ryanodine receptors: structure, expression, molecular details, and function in calcium release. |
| Q36079230 | S-Nitrosylation of cardiac ion channels |
| Q37592652 | S-nitrosation and ubiquitin-proteasome system interplay in neuromuscular disorders |
| Q33862264 | S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction. |
| Q51759239 | S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy. |
| Q36497166 | S-nitrosylation: integrator of cardiovascular performance and oxygen delivery |
| Q35789210 | Sarcoplasmic reticulum Ca2+ permeation explored from the lumen side in mdx muscle fibers under voltage control |
| Q33827719 | Sildenafil increases muscle protein synthesis and reduces muscle fatigue. |
| Q92937460 | Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy |
| Q50063914 | Single-channel recordings of RyR1 at microsecond resolution in CMOS-suspended membranes. |
| Q42918124 | Site-specific modification of calmodulin Ca2+ affinity tunes the skeletal muscle ryanodine receptor activation profile |
| Q33602302 | Skeletal muscle Ca(2+) mishandling: Another effect of bone-to-muscle signaling |
| Q36820423 | Skeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxide |
| Q92371092 | Small calcium leaks, big muscle adaptations |
| Q35250678 | Special article: Future directions in malignant hyperthermia research and patient care |
| Q34562748 | Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107 |
| Q44929041 | Stress and muscular dystrophy: a genetic screen for dystroglycan and dystrophin interactors in Drosophila identifies cellular stress response components |
| Q44740208 | Stress-induced increase in skeletal muscle force requires protein kinase A phosphorylation of the ryanodine receptor |
| Q57656681 | Structural Details of the Ryanodine Receptor Calcium Release Channel and Its Gating Mechanism |
| Q34451822 | Structure of a mammalian ryanodine receptor |
| Q37938337 | Sub-cellular targeting of constitutive NOS in health and disease |
| Q34028253 | Subcellular Ca2+ signaling in the heart: the role of ryanodine receptor sensitivity |
| Q37885158 | Targeting ryanodine receptors for anti-arrhythmic therapy |
| Q39120074 | The Role of TGFβ in Bone-Muscle Crosstalk |
| Q34505314 | The Ryanodine Receptor in Cardiac Physiology and Disease |
| Q27665591 | The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule |
| Q37946876 | The dystrophin-glycoprotein complex in the prevention of muscle damage |
| Q51625827 | The effect of taurine and β-alanine supplementation on taurine transporter protein and fatigue resistance in skeletal muscle from mdx mice. |
| Q91105830 | The panniculus carnosus muscle: A novel model of striated muscle regeneration that exhibits sex differences in the mdx mouse |
| Q38104503 | The physiological response of protease inhibition in dystrophic muscle |
| Q33630112 | The stress protein/chaperone Grp94 counteracts muscle disuse atrophy by stabilizing subsarcolemmal neuronal nitric oxide synthase. |
| Q47350159 | Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy |
| Q52756417 | Treating pediatric neuromuscular disorders: The future is now. |
| Q28484851 | Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy |
| Q35340211 | Triadopathies: an emerging class of skeletal muscle diseases |
| Q28573445 | Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy |
| Q54960330 | Very Low Volume High-Intensity Interval Exercise Is More Effective in Young Than Old Women. |
| Q35236912 | Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice |
| Q33955159 | iNOS ablation does not improve specific force of the extensor digitorum longus muscle in dystrophin-deficient mdx4cv mice |
| Q39310461 | nNOS regulation of skeletal muscle fatigue and exercise performance |
| Q64073142 | nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis |
| Q35543033 | α-Actinin-3: why gene loss is an evolutionary gain |